期刊
VACCINE
卷 41, 期 38, 页码 5494-5498出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.vaccine.2023.07.067
关键词
Malaria; Vaccine; Macaque
The development of next-generation vaccines against Plasmodium falciparum (Pf) is a priority. Many existing malaria vaccines target the pre-erythrocytic sporozoite (SPZ) and liver stages, but they require multiple doses and have suboptimal efficacy against field-transmitted malaria.
Development of next-generation vaccines against Plasmodium falciparum (Pf) is a priority. Many malaria vaccines target the pre-erythrocytic sporozoite (SPZ) and liver stages. These include subunit vaccines based on the Pf circumsporozoite protein (CSP) and attenuated PfSPZ vaccines. However, these strategies require 3-4 doses and have not achieved optimal efficacy against field-transmitted malaria. Prime-and-trap is a recently developed twostep heterologous vaccine strategy that combines priming with DNA encoding CSP followed by a single dose of attenuated SPZ. This strategy aims to induce CD8+ T cells that can eliminate parasites in the liver. Prior data has demonstrated that prime-and-trap with P. yoelii CSP and PySPZ was immunogenic and protective in mice. Here we report preliminary data on the immunogenicity of PfCSP prime and PfSPZ trap vaccine in rhesus macaques. This vaccine induced PfCSP-specific antibodies and T cell responses in all animals. However, response magnitude differed between individuals, suggesting further study is required.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据